Diagnostic accuracy in NSCLC lymph node staging with Total-Body and conventional PET/CT

IF 7.6 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING European Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2025-03-21 DOI:10.1007/s00259-025-07177-3
Clemens Mingels, Mohammad H. Madani, Fatma Sen, Hande Nalbant, Jonathan W. Riess, Yasser G. Abdelhafez, Ahmadreza Ghasemiesfe, Axel Rominger, Michele Guindani, Ramsey D. Badawi, Benjamin A. Spencer, Lorenzo Nardo
{"title":"Diagnostic accuracy in NSCLC lymph node staging with Total-Body and conventional PET/CT","authors":"Clemens Mingels, Mohammad H. Madani, Fatma Sen, Hande Nalbant, Jonathan W. Riess, Yasser G. Abdelhafez, Ahmadreza Ghasemiesfe, Axel Rominger, Michele Guindani, Ramsey D. Badawi, Benjamin A. Spencer, Lorenzo Nardo","doi":"10.1007/s00259-025-07177-3","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Introduction</h3><p>Our aim was to characterize the diagnostic accuracy indices for nodal (N)-staging with [<sup>18</sup>F]FDG Total-Body (TB) and short-axial field-of-view (SAFOV) PET/CT in non-small cell lung cancer (NSCLC) patients referred for staging or restaging.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>In this prospective single center cross-over head-to-head comparative study 48 patients underwent [<sup>18</sup>F]FDG TB and SAFOV PET/CT on the same day. In total 700 lymph node levels (1R/L, 2R/L, 3a/p, 4R/L, 5, 6, 7, 8R/L, 9R/L, 10-14R/L) of 28 patients could be correlated to a composite reference standard (histopathological correlation, imaging after localized or systemic treatment), which allowed determination of true positive (TP), false positive (FP), true negative (TN) and false negative (FN) lesions. Lymph nodes were characterized semi-quantitatively by maximum standardized uptake value (SUV<sub>max</sub>), tumor-to-background ratio (TBR), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) leading to threshold for each scanner.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>TB and SAFOV PET/CT showed high diagnostic accuracy indices for patient-based N-staging. Sensitivity and specificity were 86.0% (CI: 77.0–95.0%) and 98.3% (CI: 97.3–99.3%) for TB; 77.2% (CI: 66.3–88.1%) and 97.4% (CI: 96.1–98.6%) for SAFOV PET. Positive predictive value was higher for TB (81.7%, CI: 71.9–91.5%) compared to SAFOV PET (72.1%, CI: 60.9–83.4%). However, this finding was not statistically significant (<i>p</i> = 0.08). Negative predictive values for TB (98.6%, CI: 97.9–99.6%) and SAFOV PET/CT (98.0%, CI: 96.9–99.1%) were comparable. Overall, NSCLC N-staging was affected in six cases on SAFOV and only in one case on TB PET/CT. Semi-quantitative analysis revealed a threshold of SUV<sub>max</sub> 3.0 to detect TP lesions on both scanners. However, TBR, MTV and TLG thresholds were lower on TB compared to SAFOV PET (TBR: 1.2 vs. 1.7, MTV: 0.5 ml vs. 1.0 ml and TLG: 1.0 ml vs. 3.0 ml).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>TB and SAFOV PET/CT showed high diagnostic accuracy indices for N-staging in NSCLC patients. Sensitivity and PPV on TB PET/CT were slightly higher, compared to SAFOV PET/CT without statistical significance. However, TB PET/CT showed lower rate of incorrect N-staging and lower semi-quantitative thresholds for the detection positive mediastinal lymph nodes. Therefore, TB PET/CT might be advantageous in detecting small and low [<sup>18</sup>F]FDG-avidity mediastinal lymph node metastases in NSCLC patients.</p>","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":"34 1","pages":""},"PeriodicalIF":7.6000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Nuclear Medicine and Molecular Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00259-025-07177-3","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Our aim was to characterize the diagnostic accuracy indices for nodal (N)-staging with [18F]FDG Total-Body (TB) and short-axial field-of-view (SAFOV) PET/CT in non-small cell lung cancer (NSCLC) patients referred for staging or restaging.

Methods

In this prospective single center cross-over head-to-head comparative study 48 patients underwent [18F]FDG TB and SAFOV PET/CT on the same day. In total 700 lymph node levels (1R/L, 2R/L, 3a/p, 4R/L, 5, 6, 7, 8R/L, 9R/L, 10-14R/L) of 28 patients could be correlated to a composite reference standard (histopathological correlation, imaging after localized or systemic treatment), which allowed determination of true positive (TP), false positive (FP), true negative (TN) and false negative (FN) lesions. Lymph nodes were characterized semi-quantitatively by maximum standardized uptake value (SUVmax), tumor-to-background ratio (TBR), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) leading to threshold for each scanner.

Results

TB and SAFOV PET/CT showed high diagnostic accuracy indices for patient-based N-staging. Sensitivity and specificity were 86.0% (CI: 77.0–95.0%) and 98.3% (CI: 97.3–99.3%) for TB; 77.2% (CI: 66.3–88.1%) and 97.4% (CI: 96.1–98.6%) for SAFOV PET. Positive predictive value was higher for TB (81.7%, CI: 71.9–91.5%) compared to SAFOV PET (72.1%, CI: 60.9–83.4%). However, this finding was not statistically significant (p = 0.08). Negative predictive values for TB (98.6%, CI: 97.9–99.6%) and SAFOV PET/CT (98.0%, CI: 96.9–99.1%) were comparable. Overall, NSCLC N-staging was affected in six cases on SAFOV and only in one case on TB PET/CT. Semi-quantitative analysis revealed a threshold of SUVmax 3.0 to detect TP lesions on both scanners. However, TBR, MTV and TLG thresholds were lower on TB compared to SAFOV PET (TBR: 1.2 vs. 1.7, MTV: 0.5 ml vs. 1.0 ml and TLG: 1.0 ml vs. 3.0 ml).

Conclusion

TB and SAFOV PET/CT showed high diagnostic accuracy indices for N-staging in NSCLC patients. Sensitivity and PPV on TB PET/CT were slightly higher, compared to SAFOV PET/CT without statistical significance. However, TB PET/CT showed lower rate of incorrect N-staging and lower semi-quantitative thresholds for the detection positive mediastinal lymph nodes. Therefore, TB PET/CT might be advantageous in detecting small and low [18F]FDG-avidity mediastinal lymph node metastases in NSCLC patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
全身与常规PET/CT诊断非小细胞肺癌淋巴结分期的准确性
我们的目的是用[18F]FDG全身(TB)和短轴视场(SAFOV) PET/CT对非小细胞肺癌(NSCLC)患者进行分期或再分期的诊断准确性指标进行表征。方法在这项前瞻性单中心交叉头对头比较研究中,48例患者在同一天接受了[18F]FDG TB和SAFOV PET/CT检查。28例患者共700个淋巴结水平(1R/L、2R/L、3a/p、4R/L、5、6、7、8R/L、9R/L、10-14R/L)可与综合参考标准(组织病理相关性、局部或全身治疗后影像学)相关,确定真阳性(TP)、假阳性(FP)、真阴性(TN)、假阴性(FN)病变。通过最大标准化摄取值(SUVmax)、肿瘤与背景比(TBR)、代谢肿瘤体积(MTV)和病变总糖酵解(TLG)导致每个扫描仪的阈值,对淋巴结进行半定量表征。结果stb和SAFOV PET/CT对基于患者的n分期具有较高的诊断准确性指标。结核病的敏感性和特异性分别为86.0% (CI: 77.0-95.0%)和98.3% (CI: 97.3-99.3%);SAFOV PET阳性率分别为77.2% (CI: 66.3-88.1%)和97.4% (CI: 96.1-98.6%)。结核的阳性预测值(81.7%,CI: 71.9-91.5%)高于SAFOV PET (72.1%, CI: 60.9-83.4%)。然而,这一发现没有统计学意义(p = 0.08)。结核病(98.6%,CI: 97.9-99.6%)和SAFOV PET/CT (98.0%, CI: 96.9-99.1%)的阴性预测值具有可比性。总体而言,6例SAFOV检测影响NSCLC n分期,只有1例TB PET/CT检测影响NSCLC n分期。半定量分析显示,两种扫描仪检测TP病变的阈值均为SUVmax 3.0。然而,与SAFOV PET相比,TBR、MTV和TLG对TB的阈值较低(TBR: 1.2 vs. 1.7, MTV: 0.5 ml vs. 1.0 ml, TLG: 1.0 ml vs. 3.0 ml)。结论tb和SAFOV PET/CT对NSCLC患者n分期的诊断准确度较高。TB PET/CT的敏感性和PPV略高于SAFOV PET/CT,但无统计学意义。然而,TB PET/CT显示较低的n分期错误率和较低的半定量阈值检测阳性纵隔淋巴结。因此,TB PET/CT可能有利于检测NSCLC患者小而低[18F] fdg密度的纵隔淋巴结转移。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
15.60
自引率
9.90%
发文量
392
审稿时长
3 months
期刊介绍: The European Journal of Nuclear Medicine and Molecular Imaging serves as a platform for the exchange of clinical and scientific information within nuclear medicine and related professions. It welcomes international submissions from professionals involved in the functional, metabolic, and molecular investigation of diseases. The journal's coverage spans physics, dosimetry, radiation biology, radiochemistry, and pharmacy, providing high-quality peer review by experts in the field. Known for highly cited and downloaded articles, it ensures global visibility for research work and is part of the EJNMMI journal family.
期刊最新文献
Correction to: Total-body 11C-PIB PET/CT imaging of systemic amyloidosis: interorgan connectivity in cardiac amyloidosis for prognostic insights. Cancer-Associated Myositis: Paraneoplastic syndrome. Convection-enhanced delivery of [225Ac]Ac-DOTA-SP in recurrent glioblastoma - tumour uptake. 68Ga-MY6349 PET/CT-guided TROP2-targeted therapy in mCRPC. Individual 18F-FDG PET and arterial spin labeling coupling based on simultaneous PET/MRI predicting anti-seizure medication response in temporal lobe epilepsy patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1